Repurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age

Clinical trial NCT06643442 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06643442
Sponsor: Sebastiano Lava
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

DMD-associated Dilated Cardiomyopathy

Start date: 2025-10-01
Primary completion: 2027-03-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.